ONCAlert | Upfront Therapy for mRCC
Latest From ILCA
Advice on Decision Making for Frontline Treatment of HCC
8:26 PM, Thu September 20, 2018
Exploring Immunotherapy Combinations for the Treatment of HCC
2:21 PM, Tue September 18, 2018
Cabozantinib Improves Survival in Previously Treated Patients With HBV+ HCC
7:44 PM, Sat September 15, 2018
Recent Advancements for the Treatment of Liver Cancer
6:11 PM, Sat September 15, 2018
Deep, Durable Responses Seen With Atezolizumab Combo For Frontline HCC Treatment
3:43 PM, Sat September 15, 2018
Sequencing Strategies Necessary After Expansion of Therapy Options in HCC
8:38 PM, Fri September 14, 2018
Expert Stresses Importance of Cultivating Tailored Treatment in HCC
4:33 PM, Fri September 14, 2018
Targeted Oncology Partners With The International Liver Cancer Association
1:45 PM, Tue July 17, 2018
Finn Shares Insight on Practice-Changing Studies in Liver Cancer
1:30 PM, Wed September 20, 2017
HCC Surveillance Could Improve With Precision Screening
9:31 PM, Sun September 17, 2017
